Finance

Lists
DEVA:IST
Deva Holding AS
TRY 85.85
-1.32%
(-1.15) 1D
10-р сарын 9, 18:10:00 (GMT+3)  ·   TRY
All symbols
SymbolPriceChange% Change
Generating top insights for DEVA...
Open
TRY 87.35
High
TRY 88.30
Low
TRY 85.15
Mkt. cap
17.17 тэрбум
Avg. vol.
673.14 мян
Volume
241.60 мян
52-wk high
TRY 109.30
52-wk low
TRY 57.50
EPS
-TRY 4.21
Shares outstanding
200.02 сая
No. of employees
3 мян
Open
TRY 87.35
High
TRY 88.30
Low
TRY 85.15
Mkt. cap
17.17 тэрбум
Avg. vol.
673.14 мян
Volume
241.60 мян
52-wk high
TRY 109.30
52-wk low
TRY 57.50
EPS
-TRY 4.21
Shares outstanding
200.02 сая
No. of employees
3 мян
News stories
From web sources and news partners
Profile
DEVA Holding A.Ş. is a Turkish pharmaceutical company operating since 1958. Its principal activities include the development, manufacture and marketing of human pharmaceuticals and active pharmaceutical ingredients. The company also operates in veterinary medicines, cologne, medical ampoules and food supplements. A majority stake in the company was acquired by EastPharma in 2006. DEVA Holding is listed on Borsa Istanbul, and its chairman and chief executive officer is Philipp Haas. As of 2025, the company had more than 675 products across 15 therapeutic areas. According to IQVIA data cited in its annual report, DEVA ranked third in the Turkish pharmaceutical market by unit sales in 2025, with a market share of 4.5%. Wikipedia
About Deva Holding AS
CEO-
Employees3.06 мян
Founded1958 оны 9-р сарын 22
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in TRY
Loading Previous Earnings...
Revenue
Net income
All values in TRY
2025 оны 9-р сар
2025 оны 12-р сар
2026 оны 3-р сар
2026 оны 6-р сар
Revenue
4.47 тэрбум
5.49 тэрбум
6.33 тэрбум
6.00 тэрбум
Cost of goods sold
3.02 тэрбум
3.84 тэрбум
4.10 тэрбум
2.82 тэрбум
Cost of revenue
3.02 тэрбум
3.84 тэрбум
4.10 тэрбум
2.82 тэрбум
Research and development expenses
264.29 сая
174.34 сая
361.82 сая
480.63 сая
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.30 тэрбум
1.58 тэрбум
1.60 тэрбум
1.68 тэрбум
Operating expense
1.55 тэрбум
1.74 тэрбум
1.93 тэрбум
2.07 тэрбум
Total operating expenses
4.58 тэрбум
5.58 тэрбум
6.03 тэрбум
4.89 тэрбум
Operating income
-102.14 сая
-89.10 сая
293.59 сая
1.11 тэрбум
Other non operating income
337.87 сая
185.09 сая
663.10 сая
-172.42 сая
EBT including unusual items
-137.34 сая
-340.89 сая
585.37 сая
527.53 сая
EBT excluding unusual items
-137.34 сая
-362.51 сая
586.40 сая
527.53 сая
Income tax expense
-116.52 сая
1.00 тэрбум
682.64 сая
-86.52 сая
Effective tax rate
84.84%
-294.28%
116.62%
-16.40%
Other operating expenses
-9.80 сая
-11.48 сая
-34.86 сая
-88.91 сая
Net income
-20.81 сая
-1.34 тэрбум
-97.27 сая
614.05 сая
Net profit margin
-0.47%
-24.48%
-1.54%
10.23%
Earnings per share
-
-
-
-
Interest and investment income
59.54 сая
23.47 сая
114.43 сая
157.88 сая
Interest expense
-617.63 сая
-656.70 сая
-542.37 сая
-662.77 сая
Net interest expenses
-558.09 сая
-633.23 сая
-427.95 сая
-504.88 сая
Depreciation and amortization charges
-
-
-
-
EBITDA
237.92 сая
622.26 сая
701.87 сая
1.42 тэрбум
Gain or loss from assets sale
-15.06 сая
-15.93 сая
-32.28 сая
-12.59 сая
AI content may include mistakes. Learn more
Google аппс